At the wound site, the remodelling effect of FGF2 takes place as a result of efficient inhibition of fibroblast terminal differentiation to myofibroblast, which is a key mediator when it is activated in keloids and hypertrophic scars (Akita et al., 2013). This evidence concerns the gene FGF2 and keloid.